From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 854,166 shares, representing 1.57% for $10.18 million under the buyback announced on August 4, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.95 USD | -1.14% | +8.42% | -24.95% |
10/05 | Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating | MT |
09/05 | Health Catalyst Seeks M&A | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.95% | 410M | |
-18.97% | 217B | |
-6.57% | 68.43B | |
-0.60% | 58.01B | |
-9.15% | 47.32B | |
-1.08% | 40.16B | |
-6.62% | 34.15B | |
-9.69% | 28.61B | |
+107.00% | 27.14B | |
+5.29% | 22.06B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Tranche Update on Health Catalyst, Inc.'s Equity Buyback Plan announced on August 4, 2022.